Increased circulating CD3+/CD31+ T cells in patients with acute coronary syndrome

Area of Science:

• Immunology
• Cardiovascular Medicine
• Cell Biology

Background:

• Endothelial progenitor cells (EPCs) are key indicators for coronary artery disease (CAD).
• A novel T-cell subset, CD3(+)/CD31(+) T cells, is crucial for EPC colony formation.
• The specific role of CD3(+)/CD31(+) T cells in CAD pathogenesis requires further investigation.

Purpose of the Study:

• To investigate the clinical significance of circulating CD3(+)/CD31(+) T cells in patients with acute coronary syndrome (ACS).
• To determine if CD3(+)/CD31(+) T cell levels are elevated in ACS patients compared to healthy controls.

Main Methods:

• Quantification of circulating CD3(+)/CD31(+) T cells in 16 ACS patients undergoing percutaneous coronary intervention (PCI).
• Comparison of T-cell ratios between ACS patients and 16 control subjects with normal coronary arteries.
• Assessment of T-cell levels at baseline, 24 hours post-PCI, and 6 months post-PCI.

Main Results:

• ACS patients exhibited a significantly higher ratio of circulating CD3(+)/CD31(+) T cells compared to controls (51.8% ± 7.8% vs 31.8% ± 9.6%, P < 0.001).
• This elevated ratio remained unchanged 24 hours after PCI.
• T-cell levels in ACS patients normalized to control levels within 6 months post-PCI.

Conclusions:

• Circulating CD3(+)/CD31(+) T cells are mobilized during acute coronary syndrome.
• The increase in CD3(+)/CD31(+) T cells is a transient phenomenon, resolving within six months after PCI.
• These findings suggest a potential role for CD3(+)/CD31(+) T cells in the acute phase of ACS.